Animal models of cardiorenal syndrome: a review
- PMID: 21909828
- PMCID: PMC3324695
- DOI: 10.1007/s10741-011-9279-6
Animal models of cardiorenal syndrome: a review
Abstract
The incidence of heart failure and renal failure is increasing and is associated with poor prognosis. Moreover, these conditions do often coexist and this coexistence results in worsened outcome. Various mechanisms have been proposed as an explanation of this interrelation, including changes in hemodynamics, endothelial dysfunction, inflammation, activation of renin-angiotensin-aldosterone system, and/or sympathetic nervous system. However, the exact mechanisms initializing and maintaining this interaction are still unknown. In many experimental studies on cardiac or renal dysfunction, the function of the other organ was either not addressed or the authors failed to show any decline in its function despite histological changes. There are few studies in which the dysfunction of both heart and kidney function has been described. In this review, we discuss animal models of combined cardiorenal dysfunction. We show that translation of the results from animal studies is limited, and there is a need for new and better models of the cardiorenal interaction to improve our understanding of this syndrome. Finally, we propose several requirements that a new animal model should meet to serve as a tool for studies on the cardiorenal syndrome.
Figures
Similar articles
-
The Cardio-Renal Interrelationship.Prog Cardiovasc Dis. 2017 May-Jun;59(6):636-648. doi: 10.1016/j.pcad.2016.12.003. Epub 2016 Dec 16. Prog Cardiovasc Dis. 2017. PMID: 27993608 Review.
-
Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.Future Cardiol. 2011 Jul;7(4):485-97. doi: 10.2217/fca.11.24. Future Cardiol. 2011. PMID: 21797745 Review.
-
Target organ cross talk in cardiorenal syndrome: animal models.Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1253-63. doi: 10.1152/ajprenal.00392.2012. Epub 2012 Aug 22. Am J Physiol Renal Physiol. 2012. PMID: 22914779 Review.
-
Cardiorenal Syndrome Revisited.Circulation. 2018 Aug 28;138(9):929-944. doi: 10.1161/CIRCULATIONAHA.117.028814. Circulation. 2018. PMID: 30354446 Review.
-
Cellular apoptosis in the cardiorenal axis.Heart Fail Rev. 2016 Mar;21(2):177-89. doi: 10.1007/s10741-016-9534-y. Heart Fail Rev. 2016. PMID: 26852141 Review.
Cited by
-
Adaptive Autophagy Offers Cardiorenal Protection in Rats with Acute Myocardial Infarction.Cardiol Res Pract. 2020 Jun 20;2020:7158975. doi: 10.1155/2020/7158975. eCollection 2020. Cardiol Res Pract. 2020. PMID: 32655948 Free PMC article.
-
Pericyte detachment and renal congestion involve interstitial injury and fibrosis in Dahl salt-sensitive rats and humans with heart failure.Hypertens Res. 2023 Dec;46(12):2705-2717. doi: 10.1038/s41440-023-01451-3. Epub 2023 Oct 16. Hypertens Res. 2023. PMID: 37845397 Free PMC article.
-
CARDIO-RENAL METABOLIC SYNDROME AND PRO-INFLAMMATORY FACTORS: THE DIFFERENTIAL EFFECTS OF DIETARY CARBOHYDRATE AND FAT.Acta Endocrinol (Buchar). 2019 Oct-Dec;15(4):436-441. doi: 10.4183/aeb.2019.436. Acta Endocrinol (Buchar). 2019. PMID: 32377239 Free PMC article.
-
Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function.Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. Basic Res Cardiol. 2012. PMID: 22258067 Free PMC article.
-
Current animal models for the study of congestion in heart failure: an overview.Heart Fail Rev. 2019 May;24(3):387-397. doi: 10.1007/s10741-018-9762-4. Heart Fail Rev. 2019. PMID: 30612214 Free PMC article. Review.
References
-
- Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–2169. doi: 10.1161/01.CIR.0000095676.90936.80. - DOI - PubMed
-
- Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134:629–636. - PubMed
-
- Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, de Zeeuw D. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003;24:412–420. doi: 10.1016/S0195-668X(02)00526-2. - DOI - PubMed
-
- Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–1295. doi: 10.1056/NEJMoa041365. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources